Latest News and Press Releases
Want to stay updated on the latest news?
-
Biotech and healthcare innovators are advancing novel therapies and strategic platforms amid rising demand for targeted treatments and efficient global ac
-
Recursion OS clinical trial Jensen Huang, NVIDIA’s (NASDAQ:NVDA) CEO, is now pointing to digital biology to be the next technological wave
-
AI, healthcare technology, and digital infrastructure is a central theme dominating markets: the rapid convergence of AI with data-heavy industries
-
The Stock Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets
-
Totaligent (OTCID: TGNT) signed a binding LOI with GloMed Solutions, a Japanese medical aesthetics and biologics distribution company
-
Totaligent (OTCID: TGNT) executed a binding LOI for the acqui-hire of Aetherium Medical (https://www.aetheriummedical.com/)
-
Totaligent (OTCID: TGNT) is evaluating the potential relaunch of its crypto mining operations as part of the Company’s strategic initiatives for 2026.
-
Totaligent Wraps Up 2025 with Completion of Full Marketing Platform, Shares Holiday Message from CEO
Totaligent (OTCID:TGNT) successfully completed QA testing across its entire marketing and campaign platform; marking a major milestone
-
Totaligent is preparing the commercial launch of its all-in-one AI-powered enterprise marketing platform, designed to replace fragmented tech stacks
-
Totaligent (OTCID: TGNT) recently launched the final beta version of its AI-driven omnichannel ad platform